Marian Nakada

Marian is Vice President, Venture Investments at Johnson & Johnson Innovation – JJDC Inc. and is based in Boston. She focuses on pharm investments in East Coast companies that are in areas of strategic interest to Johnson & Johnson. Marian previously held roles at Centocor R&D, Janssen R&D, and Janssen Business Development. She has a BA in Biology from Harvard College and a PhD in Pharmacology from the University of Pennsylvania. Marian was the JJDC investor for CoStim Pharmaceuticals, Rodin Therapeutics, PhaseBio, and Padlock Therapeutics and currently sits on the Boards of Navitor Pharmaceuticals, Artizan Therapeutics, 28/7 Therapeutics, Ribon Therapeutics, the New England Venture Capital Association as well as the non-profit InnerCity Weightlifting.